|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.94 USD | +0.40% |
|
+2.65% | +0.47% |
| 06:47pm | GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update | DJ |
| 05:16pm | Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... |  |
April 29 (Reuters) - The U.S. Food and Drug Administration granted traditional approval for Pfizer's drug for cervical cancer patients with disease progression on or after chemotherapy, the agency said on Monday. (Reporting by Pratik Jain in Bengaluru; Editing by Anil D'Silva)
| 1st Jan change | Capi. | |
|---|---|---|
| +0.47% | 163B | |
| +33.10% | 709B | |
| +30.77% | 595B | |
| -1.81% | 367B | |
| +20.22% | 334B | |
| +5.96% | 289B | |
| +14.77% | 239B | |
| +9.13% | 211B | |
| -3.97% | 203B | |
| +9.29% | 171B |
PFIZER, INC. 
